Eurobio Scientific signe un accord définitif en vue de l'acquisition de la division « Lab Products » de CareDx dédiée à la transplantation
Eurobio Scientific→CareDx Lab Products division
Apr 16, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
WCAS XIV has agreed to acquire Select Medical Holdings, a healthcare services other business in Pennsylvania, for $16.50. Select Medical Holdings operates healthcare services including inpatient and outpatient care delivery, supporting patient treatment across its network in PA. WCAS XIV acquisitions in healthcare M&A focus on scaling healthcare services other platforms and strengthening operational performance in Pennsylvania. The going private acquisition is structured through a merger where MergerSub combines with Select Medical Holdings, with WCAS XIV as the private equity buyer. The announced deal is tied to a Merger Agreement dated March 2, 2026, with stockholder approval and an advisory vote on executive compensation.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Eurobio Scientific→CareDx Lab Products division
Apr 16, 2026
Quvara Medical→Becton Dickinson
Apr 15, 2026
Parkview Health→Witham Health Services
Apr 15, 2026
Surgery Partners→Preferred Vascular Group
Apr 15, 2026
Sectra→Oxipit
Apr 15, 2026